Terumo logo

4543 - Terumo Share Price

¬•4088 -5.0  -0.1%

Last Trade - 7:00am

Large Cap
Market Cap £22.23bn
Enterprise Value £23.03bn
Revenue £4.54bn
Position in Universe 36th / 3863
Unlock 4543 Revenue
Relative Strength (%)
1m +4.24%
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -6.04%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Mar 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
489,506 525,026 514,164 587,775 599,481 628,897 618,185 688,637 +5.1%
+2.8 +7.7 +7.1 +47.9 -17.8 +13.6 -10.1 +27.8
Balance Sheet
FINANCIAL BRIEF: : For the fiscal year ended 31 March 2020, Terumo Corp revenues increased 5% to Y628.9B. Net income increased 7% to Y85.21B. Revenues reflect Cardiovascular area business segment increase of 7% to Y350.55B, Hospital business segment increase of 3% to Y170.96B, Blood system business segment increase of 2% to Y107.16B, Americas segment increase of 9% to Y191.39B, Japan segment increase of 4% to Y196.34B, Asia segment increase of 4% to Y120.04B.
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Latest News & Insights for 4543
Graphical History


4543 Revenue Unlock 4543 Revenue

Net Income

4543 Net Income Unlock 4543 Revenue

Normalised EPS

4543 Normalised EPS Unlock 4543 Revenue

PE Ratio Range

4543 PE Ratio Range Unlock 4543 Revenue

Dividend Yield Range

4543 Dividend Yield Range Unlock 4543 Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
Net Profit
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
4543 EPS Forecasts Unlock 4543 Revenue
Profile Summary

TERUMO CORPORATION is a manufacturer of medical supplies. The Company operates in three segments. The Cardiac and Vascular Company segment is engaged in the manufacture of catheter system and cardiopulmonary system products, the import of the cardiopulmonary systems and artificial blood vessels, as well as the sale of products mainly to hospitals and clinics nationwide through agents. The Hospital Company segment is engaged in the manufacture, purchase and sale of hospital medical equipment, pharmaceuticals, peritoneal dialysis and diabetes related products, and the rental of hospital medical equipment and home medical products. The segment is also engaged in the manufacture and sale of healthcare related products. The Blood System Company segment is engaged in the manufacture and sale of blood transfusion-related products.

Last Annual March 31st, 2020
Last Interim March 31st, 2020
Incorporated September 17, 1921
Public Since June 21, 1982
No. of Shareholders: 37,389
No. of Employees: 26,438
Sector Healthcare
Industry Healthcare Equipment & Supplies
Index Nikkei 225 , Nikkei 300 ,
Exchange Tokyo Stock Exchange
Shares in Issue 752,284,111
Free Float (0.0%)
Eligible for
4543 Share Price Performance
Share Price
Bid - Ask
Low - High
Day's Change
Avg Volume
Open - Close
Range (12m)
Latest News for 4543
Upcoming Events for 4543
Thursday 6th August, 2020 Estimate
Q1 2021 Terumo Corp Earnings Release
Tuesday 29th September, 2020
Dividend For 4543.T - 14.0000 JPY
Monday 2nd November, 2020 Estimate
Q2 2021 Terumo Corp Earnings Presentation (Japanese)
Thursday 5th November, 2020 Estimate
Q2 2021 Terumo Corp Earnings Release
Monday 1st February, 2021 Estimate
Q3 2021 Terumo Corp Earnings Release
Monday 1st February, 2021 Estimate
Q3 2021 Terumo Corp Earnings Call (Japanese)
Frequently Asked Questions for Terumo
What is the Terumo share price?

As of 7:00am, shares in Terumo are trading at ¥4088, giving the company a market capitalisation of £22.23bn. This share price information is delayed by 15 minutes.

How has the Terumo share price performed this year?

Shares in Terumo are currently trading at ¥4088 and the price has moved by 30.27% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Terumo price has moved by 24.33% over the past year.

What are the analyst and broker recommendations for Terumo?

Of the analysts with advisory recommendations for Terumo, there are there are currently 2 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Terumo is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Terumo next release its financial results?

Terumo is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-03-31
What is the Terumo dividend yield?

The Terumo dividend yield is 0.68% based on the trailing twelve month period.

Does Terumo pay a dividend?

Last year, Terumo paid a total dividend of 28, and it currently has a trailing dividend yield of 0.68%. Looking ahead, shares in Terumo are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01.

When does Terumo next pay dividends?

Terumo are due to go ex-dividend on 2020-09-29 and the next dividend pay date is 2020-12-01. The historic dividend yield on Terumo shares is currently 0.68%.

How do I buy Terumo shares?

To buy shares in Terumo you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Terumo?

Shares in Terumo are currently trading at ¥4088, giving the company a market capitalisation of £22.23bn.

Where are Terumo shares listed? Where are Terumo shares listed?

Here are the trading details for Terumo:

Country of listing: Japan
Exchange: TYO
Ticker Symbol: 4543
What kind of share is Terumo?

Based on an overall assessment of its quality, value and momentum, Terumo is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.

Is there a Terumo share price forecast 2020?

Shares in Terumo are currently priced at ¥4088. At that level they are trading at 6.14% discount to the analyst consensus target price of 0.00.

Analysts covering Terumo currently have a consensus Earnings Per Share (EPS) forecast of 99.3 for the next financial year.

How can I tell whether the Terumo share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Terumo. Over the past six months, the relative strength of its shares against the market has been 10.05%. At the current price of ¥4088, shares in Terumo are trading at 7.98% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Terumo PE Ratio?

The Terumo PE ratio based on its reported earnings over the past 12 months is 37.05. The shares are currently trading at ¥4088.

The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.

The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.

Who are the key directors of Terumo?

Terumo's management team is headed by:

Takayoshi Mimura - CHM
Toshiaki Takagi - SME
Kazuaki Kitabatake - MEO
Shoji Hatano - MEO
Shinjiro Sato - PRE
Kyo Nishikawa - CHO
Ryo Nishihata - CFO
Hiroaki Kasukawa - CTO
Yoshihiro Kimura - DRC
Hikaru Samejima - MEO
Ikuo Mori - IND
Ryuzo Ueda - IND
Toshihiko Matsumiya - IND
Katsuya Takeuchi - CIO
Yukiko Kuroda - IND
Masaichi Nakamura - IND
Naoki Muto - CFO
Who are the major shareholders of Terumo?

Here are the top five shareholders of Terumo based on the size of their shareholding:

Nomura Asset Management Co., Ltd. Investment Advisor
Percentage owned: 8.06% (61.2m shares)
The Dai-ichi Life Insurance Company, Limited Insurance Company
Percentage owned: 5.33% (40.5m shares)
Nomura Nikkei 225 ETF Mutual Fund
Percentage owned: 5.2% (39.5m shares)
MFS Investment Management Investment Advisor/Hedge Fund
Percentage owned: 5.01% (38.0m shares)
Nikko Asset Management Co., Ltd. Investment Advisor/Hedge Fund
Percentage owned: 4% (30.4m shares)
Similar to 4543
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.